[ad_1]
Test
The European Medicines Agency recently approved the use of the Pfizer-BioNTech vaccine against covid-19 in the European Union.
“I am pleased to announce that the EMA scientific committee met today and recommended a conditional market authorization in the EU for the vaccine developed by BioNTech and Pfizer. Our scientific opinion paves the way for the first market authorization of a vaccine against covid-19 in the EU ”, announced the executive director of the entity that regulates the approval of medicines in the EU, Emer Cook.
At a press conference from Amsterdam, Cook noted that the decision “is valid for all 27 member states at the same time,” and commented that it constitutes “an important step forward in the fight against this pandemic.”
For this vaccine to begin to be marketed and administered in the EU, there is now approval by the European Commission, which should occur in 48 hours, thus allowing the vaccination campaign to start in the Member States from December 27 , as announced by the president of the community executive, Ursula von der Leyen.
[ad_2]
